Numerous cardiorespiratory disorders result in persistent systemic hypoxia, or at worst (as a consequence of stroke) deprive the brain of oxygen completely for a period of time. Patients suffering from such conditions are much more susceptible to the development of dementias such as AD (Alzheimer's disease). Until recently, the cellular and molecular basis for the predisposition to AD by systemic hypoxia has been completely unknown. However, emerging evidence suggests that pathological cellular remodelling caused by chronic hypoxia shows striking similarities to those observed in the central nervous system as a consequence of AD. Furthermore, prolonged hypoxia can induce formation of A␤s (amyloid ␤ peptides), the primary neurotoxic elements of AD, which accumulate over years to form the extracellular plaques that are the hallmark feature of the disease. Hypoxia can lead to paradoxical increases in mitochondrial ROS (reactive oxygen species) generation upstream of A␤ formation. The downstream consequences of prolonged hypoxia include remodelling of functional expression of voltage-gated calcium channels and disturbance of intracellular calcium homoeostasis via disrupted calcium buffering and inhibition of calcium extrusion mechanisms. These effects can be mimicked by application of exogenous 1 To whom correspondence should be addressed (email c.s.peers@leeds.ac.uk 
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hyperphosphorylated tau protein, see [4] for recent review). Although tangles are clearly of great importance in the disease, most research has focused on the major constituent of the extracellular plaques, A␤ (amyloid ␤ peptide), since most evidence suggests this peptide is responsible for neuronal death in AD. A␤ is a cleavage product formed by the sequential actions of two enzymes on APP (amyloid precursor protein). APP is a ubiquitously expressed, membrane-spanning protein which can undergo alternative cleavage pathways as illustrated in Figure 2 . When APP is cleaved by ␣-secretase, this occurs within the A␤ sequence, precluding A␤ formation and instead yielding sAPP␣, which is believed to be neuroprotective [5] . The identity (or identities) of the ␣-secretase remain to be fully clarifi ed, but most evidence suggests it/they belong to the ADAM (A Disintegrin And Metalloprotease) family of proteases [6] . Subsequent cleavage of the ␣-secretase product yields additional fragments which may be biologically active [2] . The alternative amyloidogenic processing of APP involves the sequential activity of two enzymes, ␤-and ␥-secretase ( Figure 2 ). ␤-secretase, also known as BACE-1 (␤-amyloid cleavage enzyme), Asp2 or memapsin2, is a single protein of the aspartyl protease family. By contrast, ␥-secretase is a protein complex, consisting of presenilin (Ϫ1 or Ϫ2, where the cleavage site resides), nicastrin, Aph-1 and Pen-2 [7] . Both ␤-and ␥-secretase present attractive therapeutic targets in AD, since both are required to liberate A␤.
It is important to note that A␤ formation is a physiological process, and there is accumulating evidence that the peptide serves important physiological roles [2] . Levels of A␤ are maintained by its clearance and degradation, the latter being a function of peptidases such as insulin-degrading enzyme, endothelinconverting enzyme and neprilysin [8] . An imbalance between the production and the removal of A␤ is believed, according to the amyloid cascade hypothesis, to account for the development of neuronal dysfunction and, ultimately, death in AD. The stages of disease progression from initiation of amyloid burden to fi nal deposition in plaques, and the consequences for neurones and other central nervous system cells during this period, currently form the basis of research interests of a large community of scientists whose common aim is to understand, and so prevent, this growing disease.
Cellular dysfunction and death in AD
The development of extracellular amyloid plaques and intraneuronal neurofibrillary tangles of hyperphosphorylated tau are well documented features of AD progression. So too is the loss of synaptic integrity and neuronal death in limbic and associated cortical regions of the brain. Less well understood, however, is the cellular and molecular basis for neuronal death. Clearly, evidence points towards A␤ causing apoptotic cell death, but the route of destruction remains to be fully evaluated [9, 10] . Nevertheless, a vast literature of studies addressing this issue has arisen over the past 15 years or so, and from such studies, some clear themes arise pointing to major pathways involved in cell death in AD. These are summarized in Figure 3 . In brief, there are two fundamental mechanisms of primary importance in A␤-induced neuronal death, one involving free radical/ROS (reactive oxygen species) generation, and the other centering on calcium dyshomoeostasis [9, 11, 12] . The whole process is complicated by the fact that these two pathways are inextricably linked at many levels. Thus, for example, increased ROS production can disrupt the functional expression of various types of ion channels, pumps and transporters, any of which can contribute to calcium homoeostasis. Disruption of calcium homoeostasis (which can even occur due to the action of presenilin, independently of its ability to generate A␤; [13] ) can lead to mitochondrial dysfunction which can lead in turn to increased ROS formation. The two pathways ultimately lead to DNA condensation and fragmentation via caspase activation, but this is by no means the only point at which these enzymes act in this pathway [10] . Further complexity is added to the system by additional factors including the involvement of NF-B (nuclear factor B; which can be protective in neurones, but destructive via oxidative damage when activated in glia [14] ) and a protective role for elevated calcium levels via PKB (protein kinase B)/Akt activation [15] . Different aspects of these pathways are championed by various laboratories, but in reality it seems we are some way yet from determining which mechanism is of primary importance, or whether both suggested pathways actually represent one complex mechanism for cell death in AD.
Hypoxic promotion of A␤ formation
Until recently, despite the clinical associations of hypoxia/ischaemia with AD, the cellular basis for such an association was unknown. However, the primary mechanisms of cellular dysfunction associated with A␤ (increased ROS production and disruption of calcium signalling; Figure 3 ) share numerous commonalities with the effects of hypoxia, prompting an examination into mechanisms by which hypoxia and AD may be linked at the cellular and molecular level. Much of our own group's efforts have been aimed at understanding this linkage, and the fundamental observation which we have made is that exposing cells in tissue culture to periods of hypoxia (1-2.5% oxygen for 6-48 h) increases the production of amyloid peptides. We have demonstrated this in a variety of cell types, including PC12 cells, HEK (human embryonic kidney)-293 cells and the human neuroblastoma, SH-SY5Y [16] [17] [18] , as well as in primary cultures of cortical astrocytes [19, 20] and, importantly, central neurones [21] . Thus this common feature seems to occur regardless of cell type. However, the mechanism by which this occurs does appear cell-specifi c. For example, in SH-SY5Y cells, hypoxia promotes suppression of ADAM10 (a candidate ␣-secretase) expression and decreases sAPP␣ secretion [22] , but in cortical astrocytes hypoxia is pro-amyloidogenic via increased expression of presenilin-1, a key component of the ␥-secretase complex [20] . Our knowledge of how hypoxia promotes amyloidogenic APP processing is still in its infancy, but the consequences of such effects have been studied in more depth, shedding more light on the mechanistic links between the damaging effects of hypoxia and the neurodegeneration of AD. Of these, we shall focus on two key aspects of pathological remodelling of cell function; (i) calcium channel expression and (ii) calcium signalling pathways.
Remodelling of calcium channel functional expression
Early studies demonstrated that chronic (24 h) hypoxia, in addition to promoting A␤ formation (see above), also potentiated depolarization-evoked, calcium-dependent neurotransmitter release, due to augmentation of calcium infl ux [16, 23] . In PC12 cells, this was confi rmed using patch-clamp recordings: hypoxia augmented the whole-cell calcium current, an effect entirely due to selective, functional up-regulation of L-type (Cav1) calcium channels, despite the presence in these cells of other voltage-activated calcium channels [24] . Importantly, this effect has also been demonstrated in primary cultures of central neurones [21] . Furthermore, hypoxic increases in whole cell calcium channel currents were also observed in HEK-293 cells stably expressing the ␣ 1C subunit of the human L-type calcium channel, Cav1.2 [17] . Use of a recombinant expression system permitted detailed examination of the underlying mechanisms, which are summarized in Figure 4 . Immediately, the reproduction of the effects of hypoxia in a recombinant expression system makes This process is disrupted in hypoxia (B) due to increased ROS production and A␤ formation. Evidence points to a possible direct interaction of A␤ with the calcium channel protein, disrupting traffi cking via an unknown mechanism which results in more active channels present in the plasma membrane. PS-1, presenilin-1. the possibility that hypoxia increases calcium channel transcription highly unlikely. Instead, we observed an increase in post-transcriptional traffi cking of L-type channels such that at any given time more were present and active in the plasma membrane, even though total cell channel content was not markedly altered. Crucially, these effects of hypoxia were inhibited by selective inhibitors of either ␤-or ␥-secretase, indicating an absolute requirement for A␤ in this process [17] . Indeed, the altered traffi cking may have resulted from a close or even direct interaction of A␤ with the calcium channel subunit, since the two proteins co-localized and co-immunoprecipitated [17] . The above-described process provides an attractive mechanism by which hypoxia could contribute to cell death in AD via disruption of calcium homoeostasis, as outlined in Figure 2 . There is also evidence for the involvement of ROS production in this phenomenon, since antioxidants prevented hypoxic up-regulation of calcium channels in the same recombinant expression system [18] . Perhaps surprisingly, ROS involvement in this mechanism appears to be upstream of A␤ formation and the ROS appeared to be derived from the mitochondrial respiratory chain, since effects were inhibited by rotenone (an electron chain transport inhibitor) and by functional mitochondrial depletion induced by sustained exposure to ethidium bromide (cells derived this way are termed 0 cells). Furthermore, exposure of 0 cells to oxidative stress, or to A␤ itself, reproduced the effects of hypoxia to increase calcium channel up-regulation [18] . Increased ROS production from mitochondria has long been associated with aging, and appears to be intimately involved with the progression of AD [25] . Furthermore, there is a growing body of evidence to suggest ROS production from mitochondria paradoxically increases during hypoxia [26] . Collectively, these data provide an attractive scheme to account for a mechanism by which hypoxia could contribute to both calcium-and ROS-mediated neuronal damage or death in AD, via disruption of calcium channel functional expression.
Hypoxic disruption of calcium signalling
Although voltage-gated calcium entry is of paramount importance in neurones, other mechanisms for regulating calcium infl ux and, indeed, intracellular calcium buffering are equally important. Indeed, in non-excitable cells such as astrocytes, voltage-gated calcium entry has little or no physiological role, and calcium signalling proceeds by entirely different mechanisms. Agonists binding to phospholipase C-coupled receptors generate IP 3 (inositol trisphosphate) which can mobilize calcium from the ER (endoplasmic reticulum) which in turn activates capacitative-(or store-operated) calcium entry. These means of calcium signalling are fundamental to numerous functions in the central nervous system and other tissues [27, 28] . Exposure of various cell types to chronic hypoxia caused apparent augmentation of agonist-evoked mobilization of calcium from ER stores and additionally modulates capacitative calcium entry [29] [30] [31] . This has been studied in depth in primary cultures of astrocytes, cells which rely heavily for many functions on intra-and inter-cellular calcium wave propagation [32] . These effects are summarized in Figure 5 . In essence, prolonged hypoxia augments agonist-evoked rises of [calcium] i not by increasing the ER calcium content, but by inhibiting clearance of calcium from the cytosol, thereby causing its accumulation. Inhibition arose in part from suppressed expression of the plasmalemmal Na + /Ca 2+ exchanger [33] , but also from calcium-loading of mitochondria. This latter effect, in turn, appeared to be due to hyperpolarization of the mitochondrial membrane potential upon which . In both cases, agonist application liberates calcium from the ER, which is normally buffered by mechanisms including extrusion on the Na + /Ca 2+ exchanger and uptake into mitochondria (A). Following chronic hypoxia (B), these two buffering mechanisms are prevented, leading to larger rises of [calcium] i when cells are exposed to the agonist. The mechanism of Na + / Ca 2+ exchanger inhibition is unknown, but the ability of mitochondria to buffer rises of [Ca 2+ ] i is due to the fact that chronic hypoxia has already caused them to become overloaded with calcium through hyperpolarization [30] . These damaging changes are associated with increased ROS levels derived from mitochondria, and increased A␤ production, presumably as a result of increased levels of the pro-amyloidogenic presenilin-1 (PS-1).
© The Authors Journal compilation © 2007 Biochemical Society calcium uptake relies [31] . Again, these effects were seen to be associated with, indeed reliant upon, increased A␤ formation and generation of ROS [20] . Thus, as with remodelling of calcium channel functional expression, perturbations in calcium homoeostasis and signalling caused by hypoxia involves proamyloidogenic processes.
Conclusions
It is clear from numerous clinical studies that conditions which disrupt oxygen delivery to the central nervous system (of which stroke is the most severe and well-documented example) promote the onset of dementias in general, and AD in particular. At the cellular level, restriction of oxygen supply promotes formation of ROS from mitochondria and disrupts the functional expression of numerous proteins associated with calcium homoeostasis, including ion channels and transporters. Strikingly, ROS production and calcium dyshomoeostasis are two recognized pathways leading to neuronal death in AD and, indeed, hypoxia also promotes formation of A␤. These cellular studies provide potential mechanisms to account for the association of hypoxic/ischaemic episodes and increased incidence of AD. In so doing, they provide clues as to targets which might prove useful in ameliorating the long-term consequences of such episodes. 
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